US Launches Tariff Probe Into Germany Over Pharma Pricing (opens original article in a new tab)

The US has initiated a tariff investigation against Germany, citing concerns over underpayment for pharmaceutical products, which could result in retaliatory levies on German goods.

• US launches tariff investigation into Germany over alleged underpayment for pharmaceutical products.
• The probe could lead to possible levies on German goods in retaliation.
• The investigation is under Section 301, allowing unilateral US action against unfair trade barriers.